Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain, Postoperative 3Head and Neck Neoplasms 2Trigger Finger Disorder 1Stomatitis 1Skin Neoplasms 1Rectal Neoplasms 1Pain 1Multiple Myeloma 1Mucositis 1Median Neuropathy 1Lymphoma 1Ileus 1Ganglion Cysts 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1De Quervain Disease 1Constipation 1Colonic Neoplasms 1Breast Neoplasms 1Agnosia 1Abnormalities, Radiation-Induced 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × oxycodone-acetaminophen × Clear all
NCT02659501 2021-01-12

Liposomal Bupivacaine in Implant Based Breast Reconstruction

Loma Linda University

Phase NA Terminated
24 enrolled 10 charts
Breast

Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡